Actuate Therapeutics, Inc. (ACTU): 3 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jun 30, 2025 | BIOS Actuate Co-Invest I, LP Director, TenPercentOwner | 71,428 | $7.00 | $500.0K | no history |
| Jun 30, 2025 | BIOS Fund II, LP Director, TenPercentOwner | 71,428 | $7.00 | $500.0K | no history |
| Jun 30, 2025 | Bios Equity COF, LP Director, TenPercentOwner | 71,428 | $7.00 | $500.0K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.